ACM
PFE icon

Aviance Capital Management’s Pfizer PFE Stock Holding History

Aviance Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,910
Closed -$121K – 251
2018
Q4 		$121K Sell
2,910
-1,285
-31% -$53.3K 0.02% 166
2018
Q3 		$175K Sell
4,195
-149,736
-97% -$5.76M 0.02% 148
2018
Q2 		$5.3M Sell
153,931
-6,569
-4% -$224K 0.44% 50
2018
Q1 		$5.4M Buy
160,500
+160,372
+125,291% +$5.51M 0.42% 54
2017
Q4 		$4K Sell
128
-92
-42% -$3.14K ﹤0.01% 254
2017
Q3 		$7K Sell
220
-202,928
-100% -$6.52M ﹤0.01% 262
2017
Q2 		$6.47M Sell
203,148
-22,661
-10% -$715K 0.4% 56
2017
Q1 		$7.33M Sell
225,809
-30,153
-12% -$951K 0.41% 60
2016
Q4 		$7.89M Sell
255,962
-65,817
-20% -$2.01M 0.42% 59
2016
Q3 		$10.3M Sell
321,779
-25,649
-7% -$858K 0.29% 80
2016
Q2 		$11.6M Sell
347,428
-24,459
-7% -$781K 0.35% 72
2016
Q1 		$10.5M Sell
371,887
-286,213
-43% -$8.18M 0.34% 71
2015
Q4 		$20.2M Buy
658,100
+5,491
+0.8% +$173K 0.66% 37
2015
Q3 		$19.4M Buy
+652,609
New +$20.9M 0.68% 44
2015
Q2 		– Sell
-714,286
Closed -$23.6M – 188
2015
Q1 		$23.6M Sell
714,286
-54,215
-7% -$1.72M 0.87% 32
2014
Q4 		$22.7M Buy
768,501
+596,251
+346% +$17.1M 0.82% 39
2014
Q3 		$4.83M Buy
+172,250
New +$4.83M 0.19% 86
2014
Q2 		– Sell
-717,562
Closed -$21.9M – 307
2014
Q1 		$21.9M Buy
717,562
+641,991
+850% +$19.1M 1.11% 26
2013
Q4 		$2.2M Sell
75,571
-2,206
-3% -$64.2K 1.17% 26
2013
Q3 		$2.12M Sell
77,777
-1,110
-1% -$30.2K 1.23% 23
2013
Q2 		$2.1M Buy
+78,887
New +$2.18M 1.15% 23

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aviance Capital Management's PFE Position: Q1 2019 in Review

Aviance Capital Management sold out of Pfizer (PFE) in Q1 2019, closing a stake of 2,910 shares — an estimated $121K sold.

Aviance Capital Management first reported a position in PFE in Q2 2013 and held it in 21 quarters. The position peaked at $23.6M in Q1 2015. 2,392 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • Aviance Capital Management reported no remaining Pfizer position as of Q1 2019 after selling out during the quarter.
  • Aviance Capital Management sold 2,910 Pfizer shares in Q1 2019, an estimated $121K.
  • Aviance Capital Management first reported a position in Pfizer in Q2 2013 and held it in 21 quarters.
  • Aviance Capital Management's Pfizer position peaked at $23.6M in Q1 2015.
  • 2,392 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Aviance Capital Management's 13F filing for Q1 2019, filed 15 May 2019.